Información*
| Nombre | GILBERTO CASTAÑEDA HERNANDEZ |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | SIN INFORMACIÓN |
| Disciplina | SIN INFORMACIÓN |
| Especialidad | APLICACIONES FARMACEUTICAS (FARMACOLOGIA) |
| CVU | 2689 |
| Institución | |
|---|---|
| Dependencia | SECCION EXTERNA DE TOXICOLOGIA |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 3 |
| Vigencia | Inicio: 01/01/2022 |
| Fin: 31/12/2036 | |
| Categoría: | EXTENSION 15 AÑOS |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2026
- Mexico regulates tissue transfers abroad for population genomics Trends in Biotechnology
- Strengthening Pharmacovigilance in Latin America: Multidisciplinary Insights from Two ISoP Latin American Chapter Symposia Drug Safety
- Bancos genómicos en México: gobernanza pública, propiedad privada y la ética del acceso controlado Latin american journal of clinical sciences and medical technology
- 2025
- Ticagrelor y AstraZeneca en México: evidencia cuestionable, confianza pública en riesgo Latin american journal of clinical sciences and medical technology
- Peripheral Antinociception Induced by Carvacrol in the Formalin Test Involves the Opioid Receptor-NO-cGMP-K+ Channel Pathway Metabolites
- Antioxidative Action of Alpha-Linolenic Acid during Its Gastroprotective Effect in an Indomethacin-Induced Gastric Injury Model Preventive Nutrition and Food Science
- Peripheral Antinociception Induced by Carvacrol in the Formalin Test Involves the Opioid Receptor-NO-cGMP-K+ Channels Pathway
- Bicomparables (biosimilares) de medicamentos huérfanos, una zona gris en la regulación de México y del mundo Latin american journal of clinical sciences and medical technology
- 2024
- Recommendations for Interchangeability in a Growing Biosimilar Market in Latin America Advances in Therapy
- Selecting the best-value biosimilar in emerging countries Exploration of Musculoskeletal Diseases